ODYSSEY Results Seen as Positive for Medicines Co. (MDCO)
Tweet Send to a Friend
Analyst Umer Raffat said Regeneron's (NASDAQ: RGEN) ODYSSEY results provided just the opening that PCSK9 class needed and by proxy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


